Log In
BCIQ
Print this Print this
 

Nexagon

  Manage Alerts
Collapse Summary General Information
Company CoDa Therapeutics Inc.
DescriptionAntisense oligonucleotide that targets gap junction protein alpha 1, 43kDa (GJA1; CX43; connexin-43)
Molecular Target Gap junction protein alpha 1, 43kDa (GJA1) (CX43) (connexin-43)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today